You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KALV Disposition Disclosure
Audhya Paul K. · SEC Form 4 · Filed Jun 11, 2026
Disposition
Reported value range
Not reported
Audhya Paul K. Chief Medical Officer
KALV
Transaction date
Jun 11, 2026
Public filing date
Jun 11, 2026
Filing lag
Filed same day
KALV daily price context
Close on/before transaction
$27
Jun 10, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit on Common Stock
- Quantity / price
- 93,750 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001860131-26-000010
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | $0 |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV | Disposition | Jun 11, 2026 | Not reported |
| Kalvista Pharmaceuticals, Inc. KALV Current | Disposition | Jun 11, 2026 | Not reported |